The Tribune

By FAY SIMMONS

Tribune Business Reporter

jsimmons@tribunemedia.net

Patients enrolled in the National Prescription Drug Plan (NPDP) are facing temporary shortages of certain medications used to treat chronic illnesses, prompting the programme to activate emergency procurement measures and seek alternative supply sources while awaiting replenishment shipments.

In a statement, the NPDP acknowledged that some prescription medications are currently unavailable because of supply challenges affecting certain products within the programme.

Officials stressed that the disruptions are temporary and limited to a relatively small number of medications.

The programme said it has been working directly with pharmaceutical wholesalers and suppliers to restore inventory levels and expects replenishment shipments to arrive over the coming days.

"Patient safety and continuity of care remain our highest priorities," the NPDP said.

"The NPDP has been in direct communication with its pharmaceutical wholesalers and suppliers, and replenishment shipments are expected to arrive over the coming days, with normal availability anticipated by the end of next week."

The acknowledgement comes as many healthcare systems worldwide continue to grapple with periodic disruptions in pharmaceutical supply chains, particularly for medications used to manage chronic conditions.

To limit the impact on beneficiaries, the NPDP said it is working closely with suppliers to secure inventory, activating emergency procurement measures where necessary and identifying clinically appropriate alternatives in consultation with healthcare providers.

Officials said additional supply sources are also being explored to strengthen the resilience of the programme's medication supply chain and reduce the risk of future disruptions.

The programme sought to reassure beneficiaries that it remains committed to providing medications covered under its existing formulary while preparations continue for the introduction of a revised drug list scheduled to take effect on August 1.

According to the NPDP, the updated formulary will feature revised medication options for the management of chronic medical conditions.

Until those changes are implemented, the programme said it will continue providing all medications available under the current plan while working to maintain access for beneficiaries affected by the shortages.

The NPDP urged patients not to discontinue prescribed treatment without consulting their physician or pharmacist and encouraged beneficiaries experiencing difficulties obtaining medications to seek professional advice regarding treatment options.

"We recognize the concern that temporary supply disruptions can cause for patients and their families and appreciate the public's patience and understanding," the statement said.

The programme added that it will continue monitoring inventory levels, coordinating with suppliers and updating healthcare providers as medication stocks are replenished.